Evidence map›Paper›PMID 40890392›Full record

ArticleNPJ digital medicine2025

Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study.

Cécile Trottet, Manuel Schürch, Ahmed Allam, Liubov Petelytska, Ivan Castellví, Radim Bečvář, Jeska de Vries-Bouwstra, Florenzo Iannone, Patricia Carreira, Marie-Elise Truchetet and 10 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Cécile TrottetDepartment of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Manuel SchürchDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Ahmed AllamDepartment of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Liubov PetelytskaDepartment of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Ivan CastellvíDepartment of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Radim BečvářInstitute of Rheumatology, Department of Rheumatology, 1st Medical School, Charles University, Prague, Czech Republic.
Jeska de Vries-BouwstraLeiden University Medical Center, Department of Rheumatology, Leiden, The Netherlands.
Florenzo IannoneRheumatology DiMePReJ, University of Bari, School of Medicine, Bari, Italy.
Patricia CarreiraHospital Universitario 12 de Octubre, Rheumatology Department, Madrid, Spain.
Marie-Elise TruchetetCHU de Bordeaux, Rheumatology Department, Bordeaux, France.
Giovanna CuomoUniversità della Campania, UOC Medicina Interna, Napoli, Italy.
Elena Rezus"Grigore T Popa" University of Medicine and Pharmacy, Rehabilitation Hospital, Department of Rheumatology, Iasi, Romania.
Francesco Paolo CantatoreUniversity of Foggia, Department of Medical and Surgical Sciences, Rheumatology Unit, Foggia, Italy.
Carmen Pilar Simeón-AznarHospital Universitario Vall d'Hebron, Department of Internal Medicine, Systemic Autoimmune Diseases Unit, Barcelona, Spain.
Magda ParvuColentina Clinical Hospital, Rheumatology Department, Bucharest, Romania.
Marta DzhusBogomolets National Medical University, Kyiv, Ukraine.
Oliver DistlerDepartment of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Anna-Maria Hoffmann-VoldDepartment of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Michael KrauthammerDepartment of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland. michael.krauthammer@uzh.ch.
EUSTAR Collaborators

Funding

Swiss National Science Foundation 201184
6 · The paper itself

Abstract

Systemic sclerosis (SSc) is a chronic autoimmune disease with multi-organ involvement. Historically, SSc classification has focused on the type of skin involvement (limited versus diffuse); however, a growing evidence of organ-specific variability suggests the presence of more than two distinct subtypes. We propose a semi-supervised generative deep learning framework leveraging expert-driven definitions of organ-specific involvement and severity. We model SSc disease trajectories in the European Scleroderma Trials and Research (EUSTAR) database, containing 14,000 patients across 67,000 medical visits, and identify clinically meaningful subtypes to enhance patient stratification and prognosis. We systematically evaluate the model's predictive accuracy, robustness to missing data, and clinical interpretability. We identified five patient clusters, separating patients based on the degree of organ involvement. Notably, a subset with limited skin involvement still showed high risks of lung and heart complications, underscoring the importance of data-driven methods and multi-organ models to complement established insights from clinical practice.

Identifiers

PMID40890392
PMCPMC12402123

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.